Tag: pharmaceutical exclusivity
Why Some Brand-Name Drugs Have No Generic Alternatives
Jan 15, 2026 / 10 Comments
Not all brand-name drugs have generic versions-even after patents expire. Complex formulations, patent tricks, and manufacturing hurdles keep prices high. Here's why some drugs stay expensive for years-and what you can do about it.
READ MORE
Market Exclusivity Extensions: How Pharma Extends Monopolies Beyond Patents
Jan 9, 2026 / 12 Comments
Market exclusivity extensions let drug companies block generics for years after patents expire. From orphan drug perks to pediatric bonuses, here's how pharma stretches monopolies-and why it costs billions.
READ MORERECENT POSTS
- UTI and IBS Connection: Causes, Symptoms & Management
- Unannounced FDA Inspections: Why Surprise Visits Are Critical for Drug and Food Safety
- ACE Inhibitors in Left Ventricular Dysfunction: Benefits, Dosing, and Monitoring
- Strattera vs Other ADHD Medications: Pros, Cons, and Best Alternatives
- Rosuvastatin vs Alternatives: Comprehensive Comparison Guide